Financial statements Explorna Therapeutics
Balance sheet of Explorna Therapeutics
Company age:
Age:
6 y. 8 m. 9 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of EXPLORNA THERAPEUTICS
|
Year
|
2019
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 267 041,48 | 16 872 492,05 | 35 267 441,44 | 34 568 285,96 |
| A. Fixed assets | 0,00 | 1 527 761,28 | 2 636 936,38 | 9 746 472,04 |
| B. Current assets | 267 041,48 | 15 344 730,77 | 32 630 505,06 | 24 821 813,92 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 267 041,48 | 16 872 492,05 | 35 267 441,44 | 34 568 285,96 |
| A. Equity | -34 278,08 | 11 421 239,38 | 30 676 119,52 | 33 433 267,02 |
| B. Liabilities and provisions for liabilities | 301 319,56 | 5 451 252,67 | 4 591 321,92 | 1 135 018,94 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 301 319,56 | 5 386 634,14 | 1 080 195,01 | 1 130 541,94 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.